Is everyone who could benefit from non-oral therapy receiving them? Know your 10%

December 12, 2017

by Sue Thomas The Non-Oral Therapy Roadshows have been a great success this year raising awareness of the potential treatments and non-oral pathways for people with Parkinson’s (PwP) who might have more complex therapy needs. Around 10% of each Parkinson’s population may require one of the non-oral therapies, namely apomorphine, deep brain stimulation or duodopa. […]

Continue Reading

MasterClass Moving On: Academy round up for 2017

December 12, 2017

by Dr Peter Fletcher As the 16th year of our Parkinson’s MasterClass(es) draws to a close it is time to take stock and reflect on 2017: more MasterClasses, more audits and two ‘Firsts’. Add to that NICE publishing new (well nearly new) guidelines, the World Parkinson’s Congress blog and the growing agenda around repurposing drugs and […]

Continue Reading

Reconsidering the “palliative phase” of Parkinson’s

December 12, 2017

by Dr Ed Richfield The model of Parkinson’s disease in four phases was first described by two founders of the original Parkinson’s MasterClass(1), and are well recognised by those familiar with the disease, particularly Academy alumni. This approach is useful in understanding the progressive nature of Parkinson’s disease (PD) and the implications this has for […]

Continue Reading

Non-oral therapy roadshows and the relevance of the NICE guidelines for Parkinson’s

December 12, 2017

by Dr Christopher Kobylecki Non-oral therapies for Parkinson’s disease comprise apomorphine infusion, deep brain stimulation (DBS) surgery, and levodopa-carbidopa intestinal gel (LCIG, Duodopa®). Whereas people with Parkinson’s disease typically respond consistently to oral medications for several years, motor fluctuations and levodopa-induced dyskinesia affect half of patients after 4-5 years (1). This heralds the “complex” phase […]

Continue Reading

James Parkinson memorial day: The man behind shaking palsy

October 23, 2017

James Parkinson FGS (11 April 1755 – 21 December 1824) was a surgeon, apothecary, geologist, palaeontologist, and political activist. He is most famous for his 1817 work, ‘An Essay on the Shaking Palsy’, in which he was the first to describe “paralysis agitans”, a condition that later became known as Parkinson’s disease.

Continue Reading

NICE Quality Standards advisory committee meeting for Parkinson’s

October 10, 2017

Public registration to observe the NICE Quality Standards committee meeting for Parkinson’s disease has opened on the NICE website. If you would like to register for this committee meeting, please do so via the following web page: https://www.nice.org.uk/event/qsac1-november-2017 Registration for this meeting will close on Thursday 19 October 2017.

Continue Reading

Come and meet us today at The Royal College of Physicians of Edinburgh

September 21, 2017

Today and tomorrow we will be at The Royal College of Physicians of Edinburgh for their two-day symposium, which will cover the management of motor and non-motor complications of Parkinson’s, updates on the latest scientific developments and the important role of multidisciplinary teams in caring for people with Parkinson’s.

Continue Reading

UK Parkinson’s Excellence Network Awards

September 20, 2017

The UK Parkinson’s Excellence Network Awards recognise and celebrate outstanding services that make a difference to people affected by Parkinson’s. Great care is already happening. Let’s celebrate it and make it standard.

Continue Reading

Roadshows offer expert half-day training courses

September 12, 2017

The Parkinson’s Academy roadshows are touring the country again offering expert MasterClass training in one afternoon for busy healthcare professionals. Courses are available on the non-oral therapies for Parkinson’s and non-motor symptoms. Following its success in 2016, the Non-Oral Therapy Roadshow is back on the road. We have re-launched a new series of this regional roadshow which explores […]

Continue Reading